|
Post by mnkdfann on Jun 23, 2019 1:23:57 GMT -5
Mike C has had only 2 years so far ... I think we need to at least give him 4 or 5 years before we see where company value is. But, that's mytakeonit If MC stays on as CEO that long, he may need a longer fireplace mantel to hold all of his APPA Pharma CEO of the Year awards.
|
|
|
Post by mnkdfann on Jun 22, 2019 22:16:52 GMT -5
Glad you feel better. Picking apart Dr. Castagna’s remarks may be fun, but the bottom-line is bullet #1. Where I’m from money talks, BS walks. I think that's the point that agedhippie was making. The CEO claims that share price was at 70 cents when he took over the CEO and agedhippie called him out by stating the share price was actually $1.55 per share. Where did the MNKD share price close last Friday? $1.15 if you don't include after hours trading. That is a valid point, but it may be that MC was thinking of the share price when he agreed to accept the role of CEO, say, some weeks before he officially took over (on May 25, 2017). The share price WAS in the 70 cents range in early May 2017. In which case, it could be that the share price was effectively 70 cents when he agreed to take over as CEO. Also, that the SP moved up in anticipation of MP leaving and the heir apparent (MC) taking over. As a partial aside, I recall how months back, when I commented about how MC may not be all he was cracked up to be, some attacked me for having that opinion. Now those same people seem to be among the most eager to get rid of MC. Funny how life is.
|
|
|
Post by mnkdfann on Jun 22, 2019 21:32:55 GMT -5
The defense calls Joe Saldanha, Mike Pfeffer, and Mrs. Mann to the witness stand. Sell tickets, and Mannkind financing secured!
|
|
|
Post by mnkdfann on Jun 22, 2019 21:17:34 GMT -5
I don't know what to believe, except I feel it is at least possible that both SDB and MC are telling the truth as they each understand it.
Though some things each said appear to be contradictory, in reality they may not be. Also, it is possible that third parties (e.g. Saldanha) may have been presenting things differently to different people.
What we don't know is the intent in everyone's mind as events were unfolding.
And I'm sure we all know that what one person says and does may easily be misinterpreted by someone else.
|
|
|
Post by mnkdfann on Jun 22, 2019 20:28:46 GMT -5
After Joe quit working for MannKind, it didn’t take long before Valeritas hired him as the company’s Chief Business Officer. “Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, today announced the appointment of Mr. Joseph Saldanha as the Company's Chief Business Officer, effective January 29, 2018.” Source: www.globenewswire.com/news-release/2018/01/09/1285901/0/en/Valeritas-Appoints-Joseph-Saldanha-as-Chief-Business-Officer.htmlAccording to Yahoo and Google Finance, VLRX has gone from about $69 a share circa January 29, 2018 (when Saldanha took over as CBO) to $2.69 on Friday. Yahoo and Google show it to be a $15 million company, a fraction the size of Mannkind, that has seen a massive loss of shareholder value over the past year. Am I supposed to be impressed Valeritas hired Saldanha? Or with Saldanha's performance at Valeritas? Both look like fails to me. Or am I looking at the wrong company? Valeritas has a nice website, though.
|
|
|
Post by mnkdfann on Jun 22, 2019 18:15:13 GMT -5
SSDD? Single Sided Double Density? Probably not what you were saying; I'm gonna have to google that acronym. Same Sh*t Different Day Believe it or not, google actually gave me the answer before you did.
|
|
|
Post by mnkdfann on Jun 22, 2019 17:53:33 GMT -5
A few years ago there was someone called Kevinmik who regularly posted on Yahoo! Message Board (now known as Yahoo! Conversations). They regularly speculated at buyout scenarios. After awhile the posts were no longer credible and the posts were often mocked. Much of the mocking appeared to be from people who were paid to bash or held short positions, so I ignored both Kevinmik, and the bashers. SSDDSSDD? Single Sided Double Density? Probably not what you were saying; I'm gonna have to google that acronym.
|
|
|
Post by mnkdfann on Jun 22, 2019 17:19:04 GMT -5
yes, the only useful info from Mike's message is VDED's business model is also not working. If that's true, that's really bad news. Now nothing seems working for promoting Afrezza. VDEX just tweeted #Truth is coming. Maybe we still have some hope. Darn, and here I am all out of popcorn.
|
|
|
Post by mnkdfann on Jun 22, 2019 17:18:17 GMT -5
I think this becoming is ridiculous. You're not an idiot, neither am I. Yes, a commission may be well deserved. I AGREE with you. The point is just that HFM DID ASK FOR A CUT OF (certain) SALES in the proposal. They asked for MORE than just distributorship rights. Your earlier post seemed to suggest they did not. That's all. My early post is about their distributor role. However if they bring a customer to Mannkind and not serve as distributor, they can get a commission. There is nothing absurd. Okay, great, then we are in agreement. HFM did ask for more than just serving as a distributor, and did ask for a cut of sales (specifically, "a commission of 4% of sales") in certain situations.
|
|
|
Post by mnkdfann on Jun 22, 2019 16:58:31 GMT -5
You may be correct that it is one or the other and the two are not cumulative (although I think it can be read either way, and is unclear) but, again, the point is they DID ASK for a cut of sales in some cases. Seriously, if you introduce a business for a company, wouldn't you ask for a commission? Or you just expect them to do that for free? I think this becoming is ridiculous. You're not an idiot, neither am I. Yes, a commission may be well deserved. I AGREE with you. The point is just that HFM DID ASK FOR A CUT OF (certain) SALES in the proposal. They asked for MORE than just distributorship rights. Your earlier post seemed to suggest they did not. That's all.
|
|
|
Post by mnkdfann on Jun 22, 2019 16:05:26 GMT -5
My point is they DID ask for a cut of sales. (And that in addition to distributorship compensation.) Your earlier post suggested they did not. It's not in addition to the distribution cut. If VDEX introduced a partner to purchase directly from MNKD, VDEX will get 4% commision. If VDEX serves as distributor, it will get the distribution cut. You may be correct that it is one or the other and the two are not cumulative (although I think it can be read either way, and is unclear) but, again, the point is they DID ASK for a cut of sales in some cases.
|
|
|
Post by mnkdfann on Jun 22, 2019 15:31:58 GMT -5
My point is they DID ask for a cut of sales. (And that in addition to distributorship compensation.) Your earlier post suggested they did not.
|
|
|
Post by mnkdfann on Jun 22, 2019 15:18:41 GMT -5
Thirdly, VDEX didn't ask to be MNKD partner. A partner would take a cut from Afrezza sales. They just want to be a distributor with similar discount MNKD gives to current distributors. Why would that be an issue? The original proposal included a cut from certain sales, above and beyond compensation as a distributor. "If HFM introduces a party who later agrees to purchase Afrezza, MannKind agrees to pay a commission of 4% of sales to HFM. If HFM functions as a distributor it will be compensated as is customary for distributors"
|
|
|
Post by mnkdfann on Jun 22, 2019 14:39:50 GMT -5
If u are an investor looking for opportunities, would you invest ur money to open up a lot of VDEX clinics in the current form? Certainly not with only 25 scripts a month from two clinics. I don't understand how Mr. McCullough thinks getting "exclusive rights" will improve that situation. Indeed, apparently <25 a month, half of which are free. "after 4 years we see <25 scripts a month out of their two centers. If they solved our fundamental challenges they would be doing better and half their scripts wouldn’t be free (ie samples, vouchers etc ultimately costing shareholders money)"
|
|
|
Post by mnkdfann on Jun 22, 2019 14:27:00 GMT -5
I appreciate the response letter from the CEO but am still troubled by his clarification that apparently he - not the Board of Directors - makes the decisions related to partnering offers. Also interesting is that the CEO bring up the issue of upfront $$$ with the VDex proposal. Brazil, India, Australia... was an indication of upfront payment required to get in the door to begin negotiations with MannKind? If you are talking about a VDEX partnership, it seems to me MC said the Board read the letter and agreed that partnership proposal wasn't one to pursue. "Bill/VDEX sent me a request for investing that valued them at $100M at which time I realized they are off in left field somewhere and didn’t respond to his updated letter until yesterday bc people didn’t believe the board was aware and wanted to let Bill know the board has read his 7 page letter, but it lacked any financial upfront money that would benefit our shareholders or give it merit for consideration.
|
|